![Muna Bhanji](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Muna Bhanji
Directeur/Membre du Conseil chez
CYTOKINETICS, INCORPORATED
Fortune : 6 M $ au 30/06/2026
Profil
Ms. Muna Bhanji is an Independent Director at Intellia Therapeutics, Inc., an Independent Director at Veracyte, Inc., an Independent Director at Ardelyx, Inc., an Independent Director at Cytokinetics, Inc., a Senior Advisor & Advisory Board Member at Arsenal Capital Management LP and a Principal at TIBA Global Access LLC.
She is on the Board of Directors at Intellia Therapeutics, Inc., Women Business Leaders of the US Health Care Industry Fnd, Womencorporatedirectors Foundation, Veracyte, Inc., Ardelyx, Inc., Cytokinetics, Inc., Corus International Ltd., Arsenal Capital Management LP, Lumanity, Inc. and Lumanity, Inc. (United States).
Ms. Bhanji was previously employed as a Senior VP-Global Market Access & Policy by Merck & Co., Inc. She also served on the board at AMCP Foundation, Nyaya Health, a Nonprofit Corp.
and Possible Health, Inc. She received her undergraduate degree from Ernest Mario School of Pharmacy and an MBA from St. Joseph's University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VERACYTE, INC. 0,06 % | 11/06/2026 | 44 582 ( 0,06 % ) | 3 M $ | 30/06/2026 |
| 27/05/2026 | 26 361 ( 0,02 % ) | 2 M $ | 30/06/2026 | |
ARDELYX, INC. 0,07 % | 16/06/2026 | 163 808 ( 0,07 % ) | 835 421 $ | 30/06/2026 |
| 09/06/2026 | 36 403 ( 0,03 % ) | 615 939 $ | 30/06/2026 |
Postes actifs de Muna Bhanji
| Sociétés | Poste | Début |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Directeur/Membre du Conseil | 17/02/2021 |
| ARDELYX, INC. | Directeur/Membre du Conseil | 11/03/2021 |
| VERACYTE, INC. | Directeur/Membre du Conseil | 19/03/2021 |
| INTELLIA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 28/04/2022 |
TIBA Global Access LLC | Fondateur | 01/01/2021 |
Women Business Leaders of the US Health Care Industry Fnd | Directeur/Membre du Conseil | 01/05/2021 |
Womencorporatedirectors Foundation | Directeur/Membre du Conseil | 01/05/2021 |
Lumanity, Inc.
 Lumanity, Inc. Packaged SoftwareTechnology Services Develops AI based software solutions for healthcare and pharma industry | Directeur/Membre du Conseil | - |
Lumanity, Inc. (United States)
 Lumanity, Inc. (United States) Data Processing ServicesTechnology Services Provides data transformation and analytics services | Directeur/Membre du Conseil | - |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Muna Bhanji
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Muna Bhanji
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Veracyte, Inc.
 Veracyte, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes diagnostic products & biopharmaceutical services | Health Technology |
Arsenal Capital Management LP
 Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital invests in middle market companies located in the United States. The firm focuses on healthcare and industrial sectors. It participates in buyouts, add-on acquisitions and growth stage capital transactions. | Finance |
St. Joseph's University
 St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Women Business Leaders of the US Health Care Industry Fnd | |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Corus International Ltd.
 Corus International Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
AMCP Foundation | |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Ernest Mario School of Pharmacy
 Ernest Mario School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Womencorporatedirectors Foundation | |
Possible Health
 Possible Health Miscellaneous Commercial ServicesCommercial Services Provides healthcare services | Commercial Services |
Possible Health, Inc.
 Possible Health, Inc. Internet Software/ServicesTechnology Services Provides online healthcare services | Technology Services |
TIBA Global Access LLC | |
Lumanity, Inc.
Lumanity, Inc. Packaged SoftwareTechnology Services Develops AI based software solutions for healthcare and pharma industry | Technology Services |
Lumanity, Inc. (United States)
Lumanity, Inc. (United States) Data Processing ServicesTechnology Services Provides data transformation and analytics services | Technology Services |
Choisissez Zonebourse 
